Among solid tumors, endometrial cancers had the highest rate of alterations in the PI3K/AKT/mTOR pathway, with 92% of type I and 60% of type II endometrial cancers having specific alterations in this pathway, indicating that PI3K/AKT plays an important role in the pathogenesis of EC53. This evidence concerns the gene AKT1 and endometrial cancer.